MARKET

CSCI

CSCI

Cosciens Biopharma
NASDAQ
3.250
+0.140
+4.50%
Opening 13:00 03/14 EDT
OPEN
2.900
PREV CLOSE
3.110
HIGH
3.260
LOW
2.723
VOLUME
20.32K
TURNOVER
--
52 WEEK HIGH
11.10
52 WEEK LOW
1.960
MARKET CAP
10.15M
P/E (TTM)
-0.4170
1D
5D
1M
3M
1Y
5Y
1D
COSCIENS Biopharma Advances Avenanthramide Clinical Trial To Phase 2a For Inflammation Treatment
NASDAQ · 21h ago
COSCIENS Initiates Phase 2a Clinical Efficacy Study Of Avenanthramides Product Being Developed For Potential Applications In Managing Conditions Related To Inflammation
Benzinga · 1d ago
COSCIENS BIOPHARMA INC. ANNOUNCES SUCCESSFUL PHASE 1 RESULTS SUPPORTING INITIATION OF PHASE 2A CLINICAL EFFICACY TRIAL WITH AVENANTHRAMIDES AS A POTENTIAL ANTI-INFLAMMATORY PRODUCT
Reuters · 1d ago
Weekly Report: what happened at CSCI last week (0303-0307)?
Weekly Report · 4d ago
HP Enterprise's outlook dims on tariffs, 'aggressive competitive pricing'
Seeking Alpha · 03/07 14:31
Weekly Report: what happened at CSCI last week (0224-0228)?
Weekly Report · 03/03 11:00
Weekly Report: what happened at CSCI last week (0217-0221)?
Weekly Report · 02/24 11:00
Weekly Report: what happened at CSCI last week (0210-0214)?
Weekly Report · 02/17 10:58
More
About CSCI
More
COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.
Recently
Symbol
Price
%Change

Webull offers COSCIENS Biopharma Inc (USA) stock information, including NASDAQ: CSCI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CSCI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CSCI stock methods without spending real money on the virtual paper trading platform.